Modified Risk Tobacco Products and Cardiovascular Repair: Still Very "Smoky"

Claudia Cozzolino1, Vittorio Picchio1, Erica Floris1

  • 1Department of Medical Surgical Sciences and Biotechnologies, Sapienza University of Rome, 04100 Latina, Italy.

Insights

Modified tobacco risk products (MRPs) may harm cardiovascular health by impairing cell repair mechanisms. Further research is needed to understand their impact on endothelial progenitor cells and cardiovascular regeneration.

Area of Science:

  • Cardiovascular Science
  • Regenerative Medicine
  • Toxicology

Background:

  • Smoking is a major cardiovascular risk factor, damaging cells and impairing repair processes like cardiac fibrosis and endothelial progenitor cell (EPC) activation.
  • Modified tobacco risk products (MRPs) are emerging alternatives, but their health effects, particularly on cardiovascular regenerative capacity, remain largely unevaluated.
  • Understanding MRPs' impact on cardiovascular repair is crucial given their potential to influence heart health and recovery.

Purpose of the Study:

  • To critically review existing data on the effects of MRPs on cardiovascular repair and regeneration at the molecular and cellular levels.
  • To assess the potential negative impacts of MRPs on crucial reparative cells, including EPCs and pluripotent stem cells.
  • To highlight the current knowledge gaps regarding MRPs' influence on cardiovascular health and recovery mechanisms.

Main Methods:

  • Literature review of scarce available data on MRPs and cardiovascular cellular mechanisms.
  • Critical analysis of studies investigating MRPs' effects on endothelial progenitor cells (EPCs) and pluripotent stem cells.
  • Evaluation of molecular and cellular pathways involved in cardiovascular repair and regeneration affected by MRPs.

Main Results:

  • Current data on MRPs' effects on cardiovascular repair and regeneration is limited.
  • Potential negative impacts on EPC activation and other reparative mechanisms are suggested but not fully characterized.
  • Further research is required to elucidate the specific cellular and molecular consequences of MRP use on cardiovascular health.

Conclusions:

  • The impact of modified tobacco risk products (MRPs) on cardiovascular repair and regeneration is not well-understood.
  • MRPs may pose risks to cardiovascular regenerative capacity, affecting cells like EPCs.
  • More research is urgently needed to characterize these risks and inform public health strategies.

Related Concept Videos

Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
292
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
30
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
30
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
1.1K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
50